Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

3.9K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.9K
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

13
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
13
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

13
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
13
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

168
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
168
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

144
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
144
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

5.5K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
5.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Short-term efficacy of increasing 0.01% atropine administration frequency in controlling myopia progression in adolescents.

BMC ophthalmology·2026
Same author

Exposure to Ketamine and 2-Fluorodeschloroketamine Impairs Mitochondrial Oxidative Phosphorylation in Human Cerebral Organoids: Implications for Neurodevelopmental Toxicity.

Current neuropharmacology·2026
Same author

Single-threshold-guided adaptive cancer therapy with partial-cycle treatment: A mechanistic and reinforcement learning analysis.

PLoS computational biology·2026
Same author

From bioinformatics to bedside: PPBP drives glioblastoma progression under hypoxia via CXCR2/PI3K/Akt signaling and is targetable by Oenothein B.

Cancer cell international·2026
Same author

The Elevational Distribution Patterns and Driving Factors of Plant Carbon Storage Across Different Functional Groups in Subalpine Grasslands of the Eastern Loess Plateau, China.

Plants (Basel, Switzerland)·2026
Same author

Evaluating patient-reported outcomes in randomized controlled trials of targeted therapy and/or immunotherapy for liver cancer: a scoping review.

Frontiers in oncology·2026
Same journal

Retraction: Flucytosine and Amphotericin B Coadministration Induces Dose-Related Renal Injury.

Dose-response : a publication of International Hormesis Society·2026
Same journal

miRNA-Targeted Herbal Compounds Against Gastric Precancerous Evolution in Chronic Atrophic Gastritis.

Dose-response : a publication of International Hormesis Society·2026
Same journal

Plant-Mediated Fabrication of Iron and Zinc Oxide Nanoparticles for Anticancer Efficacy Against HT-29 and HepG2 Cells.

Dose-response : a publication of International Hormesis Society·2026
Same journal

Total <i>Sanghuangporus vaninii</i> Extract Ameliorates Cisplatin-Induced Glioma Cell Death by Regulating Ferroptosis and Inflammation.

Dose-response : a publication of International Hormesis Society·2026
Same journal

Causal Association Between Gut Microbiota, Plasma Metabolites, and Prostate Cancer: Two-Step Mendelian Randomization Study.

Dose-response : a publication of International Hormesis Society·2026
Same journal

DMSO Protects Against Radiation-Induced Ovarian Injury by Preserving Mitochondrial Function and Alleviating DNA Damage.

Dose-response : a publication of International Hormesis Society·2026
See all related articles

Related Experiment Video

Updated: Oct 7, 2025

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

15.9K

A Universal Delayed Difference Model Fitting Dose-response Curves.

Linqian Yang1, Jiaying Wang1, Robert A Cheke2

  • 1School of Mathematics and Statistics, Shaanxi Normal University, Xi'an, China.

Dose-Response : a Publication of International Hormesis Society
|January 6, 2022
PubMed
Summary
This summary is machine-generated.

A new dynamic delayed Ricker difference model (DRDM) offers improved fitting for various dose-response curves, especially those exhibiting hormesis. This universal model enhances understanding of population dynamics compared to traditional static approaches.

Keywords:
curve fittingdata analysisdose-response curvesdynamic delayed Ricker difference model (DRDM)hormesis

More Related Videos

MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data
07:17

MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data

Published on: February 7, 2025

664
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.8K

Related Experiment Videos

Last Updated: Oct 7, 2025

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

15.9K
MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data
07:17

MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data

Published on: February 7, 2025

664
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.8K

Area of Science:

  • Environmental toxicology
  • Pharmacology
  • Ecology
  • Biostatistics

Background:

  • Dose-response curves are crucial in toxicology, physics, chemistry, and biology.
  • Existing models have limitations in universality and applicability.
  • There is a need for a novel, universal dynamical model for improved dose-response curve fitting.

Purpose of the Study:

  • To develop a novel and universal dynamical model for fitting various dose-response curves.
  • To address the limitations of existing models by incorporating inherent delays.
  • To improve the fit to diverse dose-response data, including those with hormesis.

Main Methods:

  • Expansion of the hormetic Ricker model to include inherent time delays.
  • Development of the dynamic delayed Ricker difference model (DRDM).
  • Comparison of DRDM's fitting performance against other established dose-response models using diverse datasets.

Main Results:

  • DRDM demonstrated comparable fits to monotonic dose-response data (e.g., S-shaped curves).
  • DRDM showed significantly improved fits for non-monotonic dose-response data with hormesis (e.g., U-shaped and inverted U-shaped curves) compared to traditional models.
  • Mean Squared Error (MSE) analysis confirmed DRDM's superiority for specific hormetic data types.

Conclusions:

  • The DRDM is a novel dynamic model that accurately reflects population growth trends.
  • DRDM provides an ideal description for various dose-response observations, particularly hormetic data.
  • The DRDM exhibits good universality for fitting a wide range of dose-response data.